After critically reviewing the increasing use of the term ‘neuroinflammation’ in the field of schizophrenia, the article concludes that the classical markers of a neuroinflammatory process, such a...
Read morePublished in Science Advances, the study shows that the drug does not act on the protein in isolation, but instead takes advantage of the moment when they briefly group together into small complexes (...
Read moreTopics addressed included the Mediterranean diet, physical activity, risk functions, cognitive decline and exposure to pollutants, highlighting CORDELIA’s comprehensive and multidisciplinary approac...
Read moreMonQAI is a digital platform aimed at hospitals, drug research ethics committees and clinical trial sponsors that uses generative artificial intelligence (AI) to streamline and optimize the clinical s...
Read moreA study led by IDIBELL and ICO identifies genetic variants that could modulate the body’s response to certain by-products of water purification and influence the risk of developing colorectal cancer...
Read morethe research team developed protein-based nanomedicines capable of self-assembling into multivalent nanoparticles and selectively targeting tumor cells that overexpress the CXCR4 receptor. This recept...
Read moreCompared with other antiretroviral treatments, dolutegravir leads to a more balanced microbiome, similar to that of people without HIV, with lower inflammation and reduced immune system activation
Read moreOn World Obesity Day, scientists from the Institute of Nutrition and Health at the University of Navarra present research aimed at advancing toward more personalized treatment on a portal
Read moreEl avance, realizado en IBIMA, logra identificar un 30% más de casos positivos al eliminar las interferencias en la sangre que ocultan la alergia.
Read moreEn España unos 2,5 de millones de personas sufren depresión y otros 2 millones ansiedad.
Read moreEn este nuevo estudio se observa como el consumo de uno de los antibióticos más utilizados en la erradicación para la infección por Helicobacter pylori, llamado claritromicina, disminuye la eficac...
Read morePublished today in The Lancet, these positive results could lead to the regulatory approval of pimicotinib as an effective and well-tolerated therapeutic option, representing an important step forward...
Read more